Amibegron (SR-58,611A) was a drug developed by Sanofi-Aventis (now Sanofi) which acts as a selective agonist for the β 3 adrenergic receptor. It is the first orally active β 3 agonist …

Amibegron hydrochloride is a selective β3-adrenoceptor agonist, with an EC 50 of 3.5 nM for β-adrenoceptor in rat colon; Amibegron hydrochloride has anxiolytic and antidepressant activity.

2007年11月18日 · Amibegron is an agonist for atypical beta3-adrenoceptors which inhibits intestinal motility. The next evolution of DrugBank is here. Designed for scientists, driven by …

阿米贝隆 （英语：Amibegron；开发代号： SR-58,611A）是赛诺菲-安万特（现为 赛诺菲）开发的药物，作为 β 3 肾上腺素受体 （英语：Beta-3 adrenergic receptor） 的选择性 激动剂。 它是 …

Amibegron is an agonist for atypical beta3-adrenoceptors which inhibits intestinal motility. AMIBEGRON is a small molecule drug with a maximum clinical trial phase of III (across all …

阿米替林，①用于治疗各型抑郁症或抑郁状态。 对内因性抑郁症和更年期抑郁症疗效较好，对反应性抑郁症及神经官能症的抑郁状态亦有效。 对兼有焦虑和抑郁症状的患者，疗效优于丙咪嗪 …

Amibegron Hydrochloride: 一种β3-adrenergic receptor激动剂药物，由Sanofi (Sanofi)公司最早进行研发，目前全球最高研发状态为终止，作用机制: β3-adrenergic receptor激动剂(β3-肾上腺 …

Amibegron Hydrochloride | C22H27Cl2NO4 | CID 121888 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, …

阿米拜龙是一种药物,它是β3肾上腺素受体的选择性激动剂.它是第一种口服活性β3激动剂,能够进入中枢神经系统,并具有抗抑郁和焦虑作用.

Amibegron is a selective β3-adrenoceptor agonist, with an EC 50 of 3.5 nM for β-adrenoceptor in rat colon; Amibegron has anxiolytic and antidepressant activity.